Redona

1 known investors

Redona Therapeutics develops novel therapeutics targeting enzymes involved in the dysregulation of RNA and DNA processing and signaling, which contribute to serious diseases such as cancer and autoimmune conditions. The company operates in the biotech and drug discovery space.